Markets:

Overview

News

Currencies

International

Treasuries

Avanos Medical, Inc. Common Stock (NY:AVNS)

15.01 +0.10 (+0.64%)

Streaming Delayed Price Updated: 12:00 PM EST, Feb 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Avanos Medical, Inc. Common Stock

< Previous 1 2 Next >

Expert Ratings for Avanos Medical ↗

October 11, 2022

Over the past 3 months, 4 analysts have published their opinion on Avanos Medical (NYSE:AVNS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

7 Safe Small-Cap Stocks to Buy Now ↗

August 10, 2022

Safe small-cap stocks might seem like something of an oxymoron. But these equities provide safety and growth potential nevertheless.

Via InvestorPlace

Avanos Medical: Q2 Earnings Insights ↗

August 09, 2022

Avanos Medical (NYSE:AVNS) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

7 Undervalued Small-Cap Stocks to Buy Now ↗

July 24, 2022

These undervalued small-cap stocks to buy do have value and could outperform in both the short term and long term.

Via InvestorPlace

Recap: Avanos Medical Q1 Earnings ↗

May 04, 2022

Avanos Medical (NYSE:AVNS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Avanos Medical reported in-line...

Via Benzinga

Avanos Medical's Earnings Outlook ↗

May 03, 2022

Avanos Medical (NYSE:AVNS) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Avanos...

Via Benzinga

Recap: Avanos Medical Q4 Earnings ↗

February 23, 2022

Avanos Medical (NYSE:AVNS) reported its Q4 earnings results on Wednesday, February 23, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Avanos Medical Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

April 29, 2022

Avanos Medical (NYSE:AVNS) will host a conference call at 09:00 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. How to Attend Avanos Medical (AVNS) Conference Call Follow this link to access...

Via Benzinga

The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development ↗

February 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...

Via Benzinga

Avanos Medical Earnings Preview ↗

February 22, 2022

Avanos Medical (NYSE:AVNS) is set to give its latest quarterly earnings report on Wednesday, 2022-02-23. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa ↗

February 16, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following...

Via Benzinga

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

Avanos Medical, inc (AVNS) Q3 2021 Earnings Call Transcript ↗

November 02, 2021

AVNS earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US ↗

November 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2021 ↗

August 04, 2021

Upgrades For Meritage Homes Corp (NYSE:

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗

September 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...

Via Benzinga

Avanos Medical, inc (AVNS) Q2 2021 Earnings Call Transcript ↗

August 03, 2021

AVNS earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout ↗

September 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...

Via Benzinga

Avanos Medical Shares Fall As Higher Transportation Costs Hit Q2 Margins; Lowers FY21 Guidance ↗

August 03, 2021

Avanos Medical Inc (NYSE: AVNS) reported a second-quarter FY21 adjusted EPS of $0.21, missing the consensus of $0.23. The sales of $186.4 million increased 14% Y/Y...

Via Benzinga

Avanos Medical: Q2 Earnings Insights ↗

August 03, 2021

Shares of Avanos Medical (NYSE:AVNS) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 61.54% year over year to $0.21,...

Via Benzinga

Avanos Medical, Inc. (AVNS) Q1 2021 Earnings Call Transcript ↗

May 07, 2021

AVNS earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Earnings Preview for Avanos Medical ↗

May 06, 2021

Avanos Medical (NYSE:AVNS) announces its next round of earnings this Friday, May 07. Here is Benzinga's look at Avanos Medical's Q1 earnings report. Net Income, Earnings, And...

Via Benzinga

The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗

May 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...

Via Benzinga

Earnings Scheduled For May 7, 2021 ↗

May 07, 2021

Companies Reporting Before The Bell • Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter. • Eaton Vance Municipal (NYSE:ETX) is...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.